Today’s drinkers are not simply cutting back; they are making more intentional choices. GLP-1 medications have accelerated this change, turning gradual trends into lasting habits.
Learn more
As GLP‑1 (glucagon‑like peptide‑1) therapies rapidly gain traction, the impact is rippling through the consumer packaged goods (CPG) and retail industries, specifically in food and beverage.
By now, it is clear from the media buzz surrounding new GLP - 1 diabetes drugs that usage by dieters, as well as by type 2 diabetes patients, has become an established trend.